                         SEQUENCE LISTING

<110>  CAMBRIDGE ENTERPRISE LIMITED
 
<120>  METHOD

<130>  N420793WO

<150>  GB 2101188.7
<151>  2021-01-28

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  23S-1 oligonucleotide probe

<400>  1
gcataagcgt cgctgccg                                                     18


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  23S-2 oligonucleotide probe

<400>  2
caccgtagtg cctcgtcatc a                                                 21


<210>  3
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  16S-1 oligonucleotide probe

<400>  3
ggaagggagt aaagttaata cctttgctca ttgacgttac                             40


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  16S-2 oligonucleotide probe

<400>  4
gcagcttccc agacattact                                                   20


